FDA Updates Status of Pending PMTA Applications

Apr.29.2023
FDA Updates Status of Pending PMTA Applications
FDA updates status of pending PMTA due to overwhelming amount, reaches 52% of "covered applications" by 2023.

The US Food and Drug Administration (FDA) recently updated the status of its pending market pre-tobacco product applications (PMTAs) following an order from the federal court in Maryland.

 

The influx of a large number of PMTAs has made it impossible for the FDA to complete the review of applications submitted prior to September 9, 2020, by the September 9, 2021 deadline. As a result, the court has set a final review deadline.

 

The fifth status report submitted by the FDA on April 21st states that the FDA has met its estimated review time for "covered applications" in the processing of PMTAs.

 

The American Association of Tobacco Retailers has clarified that "premarket tobacco application (PMTA) covered products" refers to new tobacco products that were already on the market as of August 8, 2016, and have had their PMTA submitted to the FDA before September 9, 2020. Brands in this category include JUUL, Vuse, NJOY, Logic, Blu, SMOK, Suorin, and Puff Bar.

 

The FDA stated in a report that as of March 31, 2023, 52% of all "covered applications" have been reviewed and action has been taken.

 

As of June 30th, this figure will reach 53%; by September 30th, it will be 55%; and by December 31st, 2023, it will reach 100%.

 

Another status report will be submitted by July 24th or earlier.

 

Further reading:

 

The United States Food and Drug Administration (FDA) has launched a new resource to assist applicants in submitting premarket tobacco product application (PMTA) requests.

 

The FDA held a public hearing where attendees claimed that TPMP would stifle innovation in new tobacco products.

 

Reference: [1] FDA Provides Updated Information on Pending PMTA Timeline.

 

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Guam checks 277 eligible retailers in 2025; eight found selling tobacco or disposable vapes to minors aged 16–20
Guam checks 277 eligible retailers in 2025; eight found selling tobacco or disposable vapes to minors aged 16–20
he Guam Behavioral Health and Wellness Center said that out of 277 eligible tobacco retailers inspected in 2025, eight were found selling tobacco or disposable e-cigarettes or vapes to minors aged 16–20, and one retailer failed to display the required “No Sale Under 21” prohibition sign.
Jan.05 by 2FIRSTS.ai
Illegal Disposable Vapes Still Sold in Nottingham Six Months After UK Ban: LBC Investigation
Illegal Disposable Vapes Still Sold in Nottingham Six Months After UK Ban: LBC Investigation
According to LBC, a follow-up investigation in Nottingham found that four out of 14 shops visited still sold illegal disposable vapes, six months after the UK Government’s ban took effect. Although fewer retailers appeared to be offering banned products compared with an earlier visit, illegal vapes remain available despite ongoing enforcement efforts.
Dec.03 by 2FIRSTS.ai
U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
The U.S. FDA has announced the agency-wide deployment of new agentic AI capabilities, providing all employees with an optional multi-step task automation tool. Building on the broad adoption of its earlier large-language-model system, Elsa, the FDA aims to use this next-generation AI workflow to accelerate product review, regulatory oversight, and internal operations, while maintaining strict human supervision and data security.
Dec.02 by 2FIRSTS.ai
British Columbia Sues Juul Over Youth Nicotine Addiction
British Columbia Sues Juul Over Youth Nicotine Addiction
British Columbia has filed a civil lawsuit against Juul Labs, alleging the company fuelled youth nicotine addiction through highly addictive products and deceptive marketing practices. The claim was submitted to the B.C. Supreme Court under the newly enacted Vaping Product Damages and Health Care Costs Recovery Act.
Dec.15 by 2FIRSTS.ai
Philip Morris International Opens IQOS Flagship Boutique in the Philippines, Featuring an IQOS Scent Experience Zone
Philip Morris International Opens IQOS Flagship Boutique in the Philippines, Featuring an IQOS Scent Experience Zone
PMFTC, the Philippine affiliate of Philip Morris International (PMI), opened an IQOS flagship boutique on December 19 in the Ayala business district of Makati City, the Philippines. Positioned as a multi-sensory, immersive retail space, the store is designed for legal-aged nicotine users. It features the Philippines’ first IQOS Scent Experience zone and also showcases the upcoming IQOS x ISABEL collaboration.
Dec.29 by 2FIRSTS.ai
Japan Tobacco Expands Ploom Aura EVO Menthol Line With Two New Products and One Upgraded Blend
Japan Tobacco Expands Ploom Aura EVO Menthol Line With Two New Products and One Upgraded Blend
Japan Tobacco Inc. (JT) has added two new EVO sticks, Evo Black Menthol and Evo Fresh Mint, to its Ploom Aura lineup and reformulated Evo Cold Menthol, creating a menthol range with three distinct levels of cooling intensity and flavor profile.
Dec.01 by 2FIRSTS.ai